Literature DB >> 11120783

Cutting edge: C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro.

D J Fitzhugh1, S Naik, S W Caughman, S T Hwang.   

Abstract

Memory T cells (mTC) express multiple chemokine receptors (including CCR4 and CCR6) that may potentially be involved in their arrest on inflamed endothelia. Herein, we specifically addressed whether CCR6 is required for mTC to arrest on TNF-alpha-activated human dermal microvascular endothelial cells (HDMEC) in vitro under shear stress conditions. Recombinant liver and activation-regulated chemokine (LARC)/CCL20 (a CCR6 ligand) induced firm arrest of cutaneous lymphocyte Ag(+) mTC in a flow chamber system using purified substrates. Strikingly, desensitization of CCR6 with LARC, but not thymus and activation-regulated chemokine/CCL17 or secondary lymphoid tissue chemokine/CCL21, caused a 50-75% decrease (p < 0. 001) in arrest of mTC on HDMEC, which was indistinguishable from the reduction observed when total mTC were treated with pertussis toxin (p > 0.5). CCR6-depleted mTC also had a markedly reduced ability to arrest on HDMEC. Our results suggest that LARC production by activated endothelial cells and CCR6 expression by mTC may be critical components in the pertussis toxin-sensitive arrest of mTC on activated HDMEC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120783     DOI: 10.4049/jimmunol.165.12.6677

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Keratinocyte Growth Factor Stimulates Macrophage Inflammatory Protein 3α and Keratinocyte-derived Chemokine Secretion by Mouse Uterine Epithelial Cells.

Authors:  Severina N Haddad; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2010-09       Impact factor: 3.886

Review 2.  Chemokine receptors and leukocyte trafficking in the mucosal immune system.

Authors:  Ifor R Williams
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Expression of the chemokine receptor CCR6 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.

Authors:  Yoshihiro Minamiya; Hajime Saito; Naoko Takahashi; Manabu Ito; Hiroshi Toda; Takashi Ono; Hayato Konno; Satoru Motoyama; Jun-Ichi Ogawa
Journal:  Tumour Biol       Date:  2010-09-25

Review 4.  Dendritic cells and contact dermatitis.

Authors:  Yoshinori Sasaki; Setsuya Aiba
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

5.  Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.

Authors:  Lena Schiffer; Ramalingam Bethunaickan; Meera Ramanujam; Weiqing Huang; Mario Schiffer; Haiou Tao; Michael P Madaio; Michael M Madaio; Erwin P Bottinger; Anne Davidson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

6.  The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.

Authors:  Thomas H Dohlman; Sunil K Chauhan; Shilpa Kodati; Jing Hua; Yihe Chen; Masahiro Omoto; Zahra Sadrai; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-12       Impact factor: 4.799

Review 7.  The immune system, the skin, and childhood rheumatic disease.

Authors:  Robert C Fuhlbrigge; Rafka Chaiban
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

Review 8.  Chemokines: control of primary and memory T-cell traffic.

Authors:  Patrick Schaerli; Bernhard Moser
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 9.  CCR6 as a possible therapeutic target in psoriasis.

Authors:  Michael N Hedrick; Anke S Lonsdorf; Sam T Hwang; Joshua M Farber
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

10.  Early CCR6 expression on B cells modulates germinal centre kinetics and efficient antibody responses.

Authors:  Dorothea Reimer; Adrian Ys Lee; Jennifer Bannan; Phillip Fromm; Ervin E Kara; Iain Comerford; Shaun McColl; Florian Wiede; Dirk Mielenz; Heinrich Körner
Journal:  Immunol Cell Biol       Date:  2016-07-28       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.